Graft Versus Host Disease
Showing NaN - NaN of 8
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)
Terminated
- Leukemia
- +2 more
- cyclosporine
- cyclosporine and methotrexate
-
Los Angeles, California
- +12 more
May 3, 2021
GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))
Completed
- Graft Versus Host Disease
- +2 more
- Autologous mesenchymal stromal cells (MSCs)
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Mar 2, 2021
B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, GVHD Trial in Australia,
Completed
- B-cell Childhood Acute Lymphoblastic Leukemia
- +5 more
- thiotepa
- +5 more
-
Phoenix, Arizona
- +49 more
Jul 24, 2019
Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,
Terminated
- Acute Leukemia
- +11 more
- Thymoglobulin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Mar 30, 2018